In this webinar , you’ll learn when and how to select the right analogs to set the most accurate expectations and payer strategy at launch. For example:

  • What are the metrics that payers use to evaluate newly launched drugs?
  • Using those metrics, how can manufacturers select an ideal analog from the vast historical launch data that Analytics + PAR provides, to most closely and accurately predict payers’ anticipated adoption of a new drug?
  • How can users overlay New to Market policies over analog data to precisely segment slow restrictive payers from fast non-restrictive payers at launch?

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.